Back
Titan Pharmaceuticals 10K Form
Sell
34
TTNP
Titan Pharmaceuticals
Last Price:
$3.61
Seasonality Move:
9.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2023-08-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2023-05-15 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-11-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-08-11 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-05-16 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
Receive TTNP News And Ratings
See the #1 stock for the next 7 days that we like better than TTNP
TTNP Financial Statistics
Sales & Book Value
| Annual Sales: | $1K |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.37 |
| Price / Book: | 0.79 |
Profitability
| EPS (TTM): | -6.54000 |
|---|---|
| Net Income (TTM): | $-5.5M |
| Gross Margin: | $60K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Titan Pharmaceuticals Earnings Forecast
Key Titan Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 27 years for TTNP is 100.00%.
-
The Selling, General & Administrative Expenses for TTNP have been equal to 554,800.00% of Gross Profit Margin.
-
The Research & Development expenses have been 191,300.00% of Revenue.
-
The Interest Expense is -5.88% of Operating Income.
-
The Net Earning history of TTNP is -556,900.00% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 19 years.
Titan Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TTNP |
| CUSIP: | 888314 |
| Website: | titanpharm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TTNP Technical Analysis vs Fundamental Analysis
Sell
34
Titan Pharmaceuticals (TTNP)
is a Sell
Is Titan Pharmaceuticals a Buy or a Sell?
-
Titan Pharmaceuticals stock is rated a SellThe current Titan Pharmaceuticals [TTNP] share price is $3.47. The Score for TTNP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.